One of the few stocks with a chart worth buying is down 12% today on a
shelf registration of "up to" $100M. This is too bad since it's an overhang for now, especially for a company of only $600M in market cap - that is potentially some serious dilution, similar to what we discussed with
Almost Family (AFAM) last week.
- Emergent BioSolutions Inc. (NYSE:EBS - News) announced today that it has filed with the U.S. Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared effective, will permit the company to issue up to an aggregate of $100 million of common stock, preferred stock, debt securities and warrants.
- Under this customary type of shelf registration, once effective, the company will have the flexibility to issue registered securities, from time to time, in one or more separate offerings or other transactions with the size, price and terms to be determined at the time of issuance.
- The registration statement also relates to the registration of 1,180,638 shares of common stock that the selling stockholders identified in the registration statement may sell from time to time.
Long Emergent BioSolutions in fund and personal account
